B. Riley Issues Negative Estimate for Abacus Life Earnings

Abacus Life, Inc. (NASDAQ:ABL) – Equities researchers at B. Riley lowered their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a research report issued on Friday, March 21st. B. Riley analyst R. Binner now expects that the company will post earnings of $0.15 per share for the quarter, down from their prior forecast of $0.16. B. Riley has a “Buy” rating and a $15.00 price target on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life’s Q2 2025 earnings at $0.17 EPS and Q4 2025 earnings at $0.23 EPS.

Abacus Life Trading Down 1.6 %

Shares of ABL opened at $7.52 on Monday. Abacus Life has a fifty-two week low of $6.75 and a fifty-two week high of $12.50. The firm has a market cap of $726.77 million, a price-to-earnings ratio of -41.78 and a beta of 0.14. The firm has a 50 day moving average price of $7.62 and a 200-day moving average price of $8.35. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29.

Institutional Trading of Abacus Life

Several hedge funds have recently added to or reduced their stakes in the business. Alyeska Investment Group L.P. grew its stake in shares of Abacus Life by 116.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 2,540,790 shares of the company’s stock valued at $19,894,000 after buying an additional 1,367,210 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in Abacus Life by 23.2% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,399,204 shares of the company’s stock worth $10,830,000 after acquiring an additional 263,036 shares during the last quarter. Royce & Associates LP increased its stake in Abacus Life by 339.9% in the 4th quarter. Royce & Associates LP now owns 1,306,431 shares of the company’s stock worth $10,229,000 after purchasing an additional 1,009,431 shares during the period. Mendon Capital Advisors Corp lifted its position in Abacus Life by 137.1% in the fourth quarter. Mendon Capital Advisors Corp now owns 1,303,826 shares of the company’s stock valued at $10,209,000 after purchasing an additional 753,826 shares during the last quarter. Finally, Curi RMB Capital LLC lifted its position in Abacus Life by 110.7% in the fourth quarter. Curi RMB Capital LLC now owns 1,159,000 shares of the company’s stock valued at $9,075,000 after purchasing an additional 609,000 shares during the last quarter.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.